Hooper J D, Nicol D L, Dickinson J L, Eyre H J, Scarman A L, Normyle J F, Stuttgen M A, Douglas M L, Loveland K A, Sutherland G R, Antalis T M
Cellular Oncology Laboratory, University of Queensland Joint Oncology Program and Queensland Institute of Medical Research, Brisbane, Australia.
Cancer Res. 1999 Jul 1;59(13):3199-205.
We have cloned and characterized a cDNA encoding a new human serine proteinase, testisin, that is abundantly expressed only in the testis and is lost in testicular tumors. The testisin cDNA was identified by homology cloning using degenerate primers directed at conserved sequence motifs within the catalytic regions of serine proteinases. It is 1073 nucleotides long, including 942 nucleotides of open reading frame and a 113-nucleotide 3' untranslated sequence. Northern and dot blot analyses of RNA from a range of normal human tissues revealed a 1.4-kb mRNA species that was present only in testis, which was not detected in eight of eight testicular tumors. Testisin cDNA is predicted to encode a protein of 314 amino acids, which consists of a 19-amino acid (aa) signal peptide, a 22-aa proregion, and a 273-aa catalytic domain, including a unique 17-aa COOH-terminal hydrophobic extension that is predicted to function as a membrane anchor. The deduced amino acid sequence of testisin shows 44% identity to prostasin and contains features that are typical of serine proteinases with trypsin-like substrate specificity. Antipeptide antibodies directed against the testisin polypeptide detected an immunoreactive testisin protein of Mr 35,000-39,000 in cell lysates from COS-7 cells that were transiently transfected with testisin cDNA. Immunostaining of normal testicular tissue showed that testisin was expressed in the cytoplasm and on the plasma membrane of premeiotic germ cells. No staining was detected in eight of eight germ cell-derived testicular tumors. In addition, the testisin gene was localized by fluorescence in situ hybridization to the short arm of human chromosome 16 (16p13.3), a region that has been associated with allellic imbalance and loss of heterozygosity in sporadic testicular tumors. These findings demonstrate a new cell surface serine proteinase, loss of which may have a direct or indirect role in the progression of testicular tumors of germ cell origin.
我们已经克隆并鉴定了一种编码新型人类丝氨酸蛋白酶(睾丸丝氨酸蛋白酶)的cDNA,该蛋白酶仅在睾丸中大量表达,而在睾丸肿瘤中缺失。睾丸丝氨酸蛋白酶cDNA是通过同源克隆鉴定的,使用针对丝氨酸蛋白酶催化区域内保守序列基序的简并引物。它长1073个核苷酸,包括942个核苷酸的开放阅读框和113个核苷酸的3'非翻译序列。对一系列正常人组织的RNA进行Northern和斑点印迹分析显示,一种1.4kb的mRNA仅存在于睾丸中,在8个睾丸肿瘤中的8个中未检测到。睾丸丝氨酸蛋白酶cDNA预计编码一种由314个氨基酸组成的蛋白质,该蛋白质由19个氨基酸的信号肽、22个氨基酸的前肽区和273个氨基酸的催化结构域组成,包括一个独特的17个氨基酸的COOH末端疏水延伸,预计其作为膜锚定发挥作用。睾丸丝氨酸蛋白酶推导的氨基酸序列与前列腺丝氨酸蛋白酶显示44%的同一性,并包含具有胰蛋白酶样底物特异性的丝氨酸蛋白酶的典型特征。针对睾丸丝氨酸蛋白酶多肽的抗肽抗体在瞬时转染了睾丸丝氨酸蛋白酶cDNA的COS-7细胞的细胞裂解物中检测到一种Mr为35000-39000的免疫反应性睾丸丝氨酸蛋白酶蛋白。正常睾丸组织的免疫染色显示,睾丸丝氨酸蛋白酶在减数分裂前生殖细胞的细胞质和质膜中表达。在8个生殖细胞源性睾丸肿瘤中的8个中未检测到染色。此外,通过荧光原位杂交将睾丸丝氨酸蛋白酶基因定位到人类染色体16的短臂(16p13.3),该区域与散发性睾丸肿瘤中的等位基因失衡和杂合性缺失有关。这些发现证明了一种新的细胞表面丝氨酸蛋白酶,其缺失可能在生殖细胞源性睾丸肿瘤的进展中具有直接或间接作用。